Uterine tumours with myogenic differentiation harbouring SRF:RELA fusions. Issue 4 (3rd August 2022)

• Record Type: Journal Article
• Authors: Li, Yimin; Huang, Dan; Bi, Rui; Yao, Qianlan; Ge, Ling; Yu, Lin; Zhou, Xiaoyan; Yang, Wentao
• Is Part Of: Histopathology. Volume 81:Issue 4(2022)
• Page Start: 477
• Page End: 485
• Publication Date: 2022-08-03
• Subjects: myofibroma -- myopericytoma -- RELA -- SRF -- uterine tumour; Histology, Pathological -- Periodicals; 611.018
• DOI: 10.1111/his.14724
• Languages: English
• ISSNs: 0309-0167

Abstract

Abstract : Aims: In 2017, a subset of cellular variants of myofibroma and myopericytoma with a smooth muscle‐like immunophenotype and harbouring recurrent SRF::RELA gene fusions was reported. Although the anatomical distribution was found to be quite broad, no tumours with these gene fusions in the female reproductive system have been illustrated to date. Methods and results: Herein, we report the histological and immunophenotypical features of three uterine tumours with SRF::RELA gene fusions. Microscopically, all three tumours were composed of cellular oval to spindle cells arranged in intersecting fascicles with variable amounts of collagen and a rich capillary network. Mitotic figures were scant. Regarding immunohistochemistry, diffuse staining for desmin, oestrogen receptor and progesterone receptor was observed in all three cases. The first case exhibited focal staining for h‐caldesmon, whereas the latter two cases had diffuse staining. Furthermore, SRF::RELA rearrangement was observed in all three cases by using next‐generation sequencing (NGS). Follow‐up, ranging from 11 to 15 months, was available for these three patients, all of whom were well without evidence of disease. Conclusions: In conclusion, we reported a special group of uterine neoplasms with myogenic differentiation harbouring SRF::RELA rearrangement. Although the follow‐up time was limited, morphological characteristics and other studies with follow‐up data supported that this type of uterine neoplasm appeared to behave in a benign manner. Further studies with longer follow‐up are needed to clarify the biological nature of this particular type of uterine tumour. Abstract :